[MS26] Mini Symposium 26
Treatment for adult asthma 2

[MS26-3] Efficacy of single inhaler, once-daily indacaterol/glycopyrronium/mometasone furoate in inadequately controlled asthma: a post-hoc Asian population analysis of the IRIDIUM study

Hironori Sagara¹, Nathalie Barbier², Tsuyoshi Ishii³, Hajime Yoshisue³, Ivan Nikolaev², Ioannis Kottakis², Yasuhiro Gon⁴ (1.Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Japan, 2.Global Medical Affairs Novartis Pharma AG, Switzerland, 3.Novartis Pharma K.K., Japan, 4.Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Japan)